Macroview Investment Management LLC Blueprint Medicines Corp Transaction History

Macroview Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	BUY	$85.18 - $108.78 $5,962 - $7,614	70 New	70 $7,000
Q1 2022 May 02, 2022	SELL	$54.1 - $110.08 $9,575 - $19,484	-177 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$94.25 - $115.99 $16,682 - $20,530	177 New	177 $19,000
Q4 2020 Jan 29, 2021	SELL	$92.08 - $124.48 $2,762 - $3,734	-30 Closed	0 $0
Q3 2020 Oct 23, 2020	SELL	$66.45 - $92.7 $664 - $927	-10 Reduced 25.0%	30 $3,000
Q2 2020 Aug 11, 2020	BUY	$57.09 - $79.27 $2,283 - $3,170	40 New	40 $3,000

351

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.47B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Macroview Investment Management LLC with notifications on news.